Modern Medicine Cases

2017 Payer Scorecard breakdownAn inside look at what drives insurers to refuse to negotiate, require more prior auths and deny claims
Here's why physicians need to stay the course with MACRAStaying the course is the best option
How to survive an EHR outageMost physicians have plans for responding to computer system failures, but many don’t revisit those disaster recovery/business continuity plans with any regularity.
Your Voice: Stop hating EHRs and do this insteadStop hating EHRs and do this
What is and what isn't in a credit scoreWhether it’s to expand the office, upgrade technology or buy new equipment, a physician’s credit score will determine how much funding for which you’re approved.
Kung fu insurance providersPayer negotiations made simple.
Will retail take over primary care?
Will retail take over primary care?Walgreens and CVS pharmacy chains are aggressively developing primary care venues within their stores. Their approaches are similar yet different, although the underlying strategy is the same for both.
How federal policy has worsened the U.S. primary care shortage
How federal policy has worsened the U.S. primary care shortageLoud and clear warnings forecasting the current shortage of primary care physicians in the United States date back to the early 2000s.
Investigational wet AMD therapies aim for innovative targetsMany investigational drugs under development for the treatment of neovascular age-related macular degeneration (nvAMD) have advanced into the clinical trial stage, including several that are being evaluated in pivotal trials, said Peter K. Kaiser, MD.
Failed cell therapy study offers positives, raises new questionsPatients with a history of frequent anti-vascular endothelial growth factor (anti-VEGF) injections for the treatment of age-related macular degeneration (AMD) may not be the best potential candidates for encapsulated cell technology (ECT).